KR830001941A - β-락타마제-억제제로서의 6-B-치환 페닐실란산의 제조방법 - Google Patents

β-락타마제-억제제로서의 6-B-치환 페닐실란산의 제조방법 Download PDF

Info

Publication number
KR830001941A
KR830001941A KR1019800000921A KR800000921A KR830001941A KR 830001941 A KR830001941 A KR 830001941A KR 1019800000921 A KR1019800000921 A KR 1019800000921A KR 800000921 A KR800000921 A KR 800000921A KR 830001941 A KR830001941 A KR 830001941A
Authority
KR
South Korea
Prior art keywords
carboxy protecting
integer
chlorine
carbon atoms
group
Prior art date
Application number
KR1019800000921A
Other languages
English (en)
Other versions
KR840000589B1 (ko
Inventor
스테펜 켈로그 미카엘
세이치 하마나카 어네스트
Original Assignee
테렌스 제이. 갤 라퍼
파이저 인코포레이숀
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 테렌스 제이. 갤 라퍼, 파이저 인코포레이숀 filed Critical 테렌스 제이. 갤 라퍼
Publication of KR830001941A publication Critical patent/KR830001941A/ko
Application granted granted Critical
Publication of KR840000589B1 publication Critical patent/KR840000589B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

내용 없음

Description

β-락타마제-억제제로서의 6-B-치환 페닐실란산의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 다음 구조식(Ⅴ) 또는 약리학적으로 허용되는 이들의 염기성으로 구성되는 군의 화합물.
    상기 구조식에서
    R는 불소, 염소 및 요드원자, 플루오로메틸, 클로로메틸, 브로모메틸, 1개 내지 4개 탄소원자의 알콕시 또는 1개 내지 4개 탄소원자의 알킬티오이고,
    n은 0 내지 2의 정수이며,
    R1은 페니실린 카르복시 보호기들이다.
    단 R이 알킬티오, 염소, 또는 요드원자인 경우 n은 0 내지 1의 정수이다.
  2. 6-α-브로모에피머를 거의 함유하지 않는 구조식(Ⅵ)화합물군 또는 약리학적으로 허용되는 이들의 염기염 화합물.
    상기 구조식에서 R14는 페니실린 카르복시 보호기들이다.
  3. 다음 구조식(Ⅰ)의 화합물을 유기주석 1수소화물(Organotin monohydride)과 약 0 내지 110℃에서 반응시키고 R19가 기존의 페니실린 카르복시 보호기인 경우는 이어서 R19를 제거하여 다음 구조식(Ⅱ)군의 화합물을 제조하는 방법.
    상기 구조식에서
    R15는 불소, 염소 브롬, 및 요드원자, 1개 내지 4개 탄소원자 알콕시 및 1개 내지 4개 탄소원자 알킬티오이고,
    n은 0 내지 2의 정수이며,
    R13은 수소 또는 생체내에서 쉽게 가수분해되는 에스테르 형성 잔유기이고,
    X는 염소, 브롬 또는 요드원자이며
    또는 R19는 생체내에서 쉽게 가분해 되는 에스테르 형성 잔유기 또는 기존의 페니실린 카르복시 보호기이다. 단 R19가 기존의 페니실린 카르복시 보호기인 경우
    n은 0내지 1의 정수이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800000921A 1979-03-05 1980-03-04 6-β-치환된 페니실란산의 제조방법 KR840000589B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1780979A 1979-03-05 1979-03-05
US17809 1979-03-05
US017809 1979-03-05
US96832 1979-11-23
US06/096,832 US4397783A (en) 1979-03-05 1979-11-23 Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners

Publications (2)

Publication Number Publication Date
KR830001941A true KR830001941A (ko) 1983-05-19
KR840000589B1 KR840000589B1 (ko) 1984-04-24

Family

ID=26690341

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800000921A KR840000589B1 (ko) 1979-03-05 1980-03-04 6-β-치환된 페니실란산의 제조방법

Country Status (29)

Country Link
US (1) US4397783A (ko)
KR (1) KR840000589B1 (ko)
AR (1) AR225758A1 (ko)
AT (1) AT369744B (ko)
AU (1) AU518472B2 (ko)
CA (1) CA1154011A (ko)
CH (1) CH648850A5 (ko)
DD (1) DD149366A5 (ko)
DE (1) DE3008316C2 (ko)
DK (1) DK157136C (ko)
ES (1) ES489186A0 (ko)
FI (1) FI71739C (ko)
FR (1) FR2450837A1 (ko)
GB (1) GB2047684B (ko)
GR (1) GR67697B (ko)
HK (1) HK66687A (ko)
IE (1) IE51931B1 (ko)
IL (1) IL59514A (ko)
IT (1) IT1130301B (ko)
KE (1) KE3456A (ko)
LU (1) LU82219A1 (ko)
MY (1) MY8500320A (ko)
NL (1) NL8001286A (ko)
NO (1) NO800617L (ko)
OA (1) OA06496A (ko)
PH (2) PH18550A (ko)
PT (1) PT70898A (ko)
SE (1) SE451329B (ko)
SG (1) SG56484G (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518530A (en) * 1979-03-05 1985-05-21 Pfizer Inc. 6-β-Substituted penicillanic acids as β-lactamase inhibitors
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
GB8522156D0 (en) * 1985-09-06 1985-10-09 Leo Pharm Prod Ltd Producing chemical compounds
WO1987006230A1 (en) * 1986-04-10 1987-10-22 Leo Pharmaceutical Products Ltd. A/S Method for preparing penicillanic acid derivatives
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
EP1636240A1 (en) * 2003-06-05 2006-03-22 Pfizer Products Inc. Beta-lactamase inhibitor prodrug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5749555B2 (ko) * 1973-04-04 1982-10-22
US4093625A (en) * 1976-08-09 1978-06-06 Massachusetts Institute Of Technology 6-Sulfur analogs of penicillins and cephalosporins
US4180506A (en) * 1978-01-18 1979-12-25 Rex Pratt 6β-Bromo penicillanic acid
US4203992A (en) * 1978-12-11 1980-05-20 E. R. Squibb & Sons, Inc. β-Bromopenicillanic acid sulfone
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IL59081A0 (en) * 1979-01-10 1980-05-30 Schering Corp 2-penem compounds and a method for preparing them
DE3068390D1 (en) * 1979-01-10 1984-08-09 Beecham Group Plc Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds

Also Published As

Publication number Publication date
AU5610580A (en) 1980-09-18
PH18550A (en) 1985-08-09
NO800617L (no) 1980-09-08
ES8103095A1 (es) 1981-02-16
NL8001286A (nl) 1980-09-09
IL59514A (en) 1984-01-31
KR840000589B1 (ko) 1984-04-24
HK66687A (en) 1987-09-25
KE3456A (en) 1984-10-12
GR67697B (ko) 1981-09-07
FI71739B (fi) 1986-10-31
SE451329B (sv) 1987-09-28
CH648850A5 (de) 1985-04-15
DE3008316C2 (de) 1982-12-16
PH17879A (en) 1985-01-14
LU82219A1 (fr) 1980-09-24
SG56484G (en) 1985-03-08
IE800428L (en) 1980-09-05
FI800662A (fi) 1980-09-06
FI71739C (fi) 1987-02-09
IL59514A0 (en) 1980-06-30
DD149366A5 (de) 1981-07-08
IE51931B1 (en) 1987-04-29
IT8020368A0 (it) 1980-03-05
US4397783A (en) 1983-08-09
AU518472B2 (en) 1981-10-01
DE3008316A1 (de) 1980-09-25
ES489186A0 (es) 1981-02-16
GB2047684A (en) 1980-12-03
AR225758A1 (es) 1982-04-30
MY8500320A (en) 1985-12-31
OA06496A (fr) 1981-07-31
CA1154011A (en) 1983-09-20
DK157136B (da) 1989-11-13
SE8001689L (sv) 1980-09-06
DK92880A (da) 1980-09-06
FR2450837A1 (fr) 1980-10-03
IT1130301B (it) 1986-06-11
AT369744B (de) 1983-01-25
PT70898A (en) 1980-04-01
GB2047684B (en) 1983-09-28
FR2450837B1 (ko) 1984-01-13
DK157136C (da) 1990-04-16
ATA118980A (de) 1982-06-15

Similar Documents

Publication Publication Date Title
KR850003890A (ko) 1H-이미다조[4,5c]-퀴놀린-4-아민의 제조방법
KR830010112A (ko) 9-(1,3-디하이드록시-2-프로폭시메틸)-구아닌의 제조방법
KR830001947A (ko) 화합물의 제조방법
KR830001941A (ko) β-락타마제-억제제로서의 6-B-치환 페닐실란산의 제조방법
KR850001905A (ko) 벤조시클로 알칸 유도체의 제조방법
KR830004315A (ko) 아실 유도체의 제조방법
KR840000463A (ko) 광학적으로 활성인 1-방향족 그룹으로 치환된-1- 알카논의 제조방법
SE7602144L (sv) Kvaternera imidazoliumforeningar
KR850003539A (ko) 밀베마이신 5-카르보네이트 유도체의 제조방법
KR920701103A (ko) 개선된 비닐에테르 제조방법
KR840000557A (ko) 항균성 페넴 유도체
KR840007007A (ko) 플루오로메틸티오옥사세팔로스포린의 제조방법
KR860001048A (ko) 플루오로알릴아민 유도체의 제조방법
KR840005723A (ko) 티아졸유도체의 제조방법
KR840005453A (ko) 펜엠 유도체의 제조방법
KR840004065A (ko) 2-시아노-2-프로페노산 및 그 유도체의 제조방법
KR860002517A (ko) 트리스(β,β-디메틸펜에틸) 주석 화합물의 제조방법
KR830001292A (ko) 3-엑소메틸렌세팜 설폭사이드류의 제법
AU539870B2 (en) 2-phenylamino-imidazolines-(2)
KR850004470A (ko) 유기 화합물의 제조방법
KR830001955A (ko) β-락탐 화합물의 할로겐화 반응물 제조방법
KR830001943A (ko) 페니실린과 세팔로스포린 이미노할라이드의 제조방법
KR830006265A (ko) 복소환 화합물의 제조방법
KR880001673A (ko) 세팔로스포린 유도체의 제조방법
KR830005234A (ko) 페니실린 에피머화 방법